Dopamet en es it fr

Dopamet Brand names, Dopamet Analogs

Dopamet Brand Names Mixture

  • No information avaliable

Dopamet Chemical_Formula


Dopamet RX_link

Dopamet fda sheet

Dopamet FDA

Dopamet msds (material safety sheet)

Dopamet MSDS

Dopamet Synthesis Reference

No information avaliable

Dopamet Molecular Weight

1270.28 g/mol

Dopamet Melting Point

No information avaliable

Dopamet H2O Solubility

Freely soluble as sodium salt (> 200mg/mL)

Dopamet State


Dopamet LogP

No information avaliable

Dopamet Dosage Forms

Powder for solution (for injection)

Dopamet Indication

For use in the treatment of patients with esophageal candidiasis and prophylaxis of Candida infections in patients undergoing hematopoietic stem cell transplantation.

Dopamet Pharmacology

Formerly known as FK463, micafungin is a novel antifungal agent. It is a glucan synthesis inhibitor of the echinocandin structural class. The U.S. Food and Drug Administration approved micafungin in March 2005. Micafungin inhibits an enzyme essential for fungal cell-wall synthesis and is fungicidal (lethal) for Candida. Micafungin can be used concomitantly with a variety of other drugs, including the HIV protease inhibitor ritonavir and the transplant medications cyclosporine and tacrolimus.

Dopamet Absorption

No information avaliable

Dopamet side effects and Toxicity

Intravenous LD50 in rats is 125mg/kg. In dogs it is >200mg/kg. No cases of overdosage have been reported. Repeated daily doses up to 8 mg/kg (maximum total dose of 896 mg) in adult patients have been administered in clinical trials with no reported dose-limiting toxicity. The minimum lethal dose is 125 mg/kg in rats, equivalent to 8.1 times the recommended human clinical dose for esophageal candidiasis based on body surface area comparisons.

Dopamet Patient Information

No information avaliable

Dopamet Organisms Affected

Aspergillis, Candida and other fungi